Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX in Comparison With 150 IU Gonal-f in Women Undergoing ICSI Treatment.

Next Previous
Trial Profile

A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX in Comparison With 150 IU Gonal-f in Women Undergoing ICSI Treatment.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Follicle-stimulating hormone glyco-optimised (Primary) ; Follitropin alfa
  • Indications Female infertility
  • Focus Biomarker; Pharmacodynamics
  • Sponsors Glycotope

    • Most Recent Events

    • 26 Mar 2014 Status changed from active, no longer recruiting to completed, as per European Clinical Trials Database record.
    • 19 Jun 2013 The trial is expected to report at the beginning of the fourth quarter of 2013, according to a Glycotope media release.
    • 19 Jun 2013 Status changed from recruiting to active, no longer recruiting, according to a Glycotope media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top